FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis

FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis Print this page NORTH CHICAGO, Ill., Aug. 16, 2019 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), a 15 mg, once-daily oral… Read More »

How to help children cope with acne – AZ Big Media

The emotional rollercoaster many teens and pre-teens experience can become worse this time of year. Back to school can add stress in a variety of ways: busier schedules, more responsibilities and social challenges. Adding acne to the mix can sometimes feel overwhelming. The experts at Affiliated Dermatology offer some advice on how to help children… Read More »